Values Delek US as its publicly traded DKL stake plus a normalized refining and corporate enterprise value, less standalone net debt. Q2 peak-cycle refining results are not annualized; base EBITDA remains a conservative mid-cycle assumption after excluding RVO benefits.
as of 2026-09-30
| Current | |
|---|---|
| Refining and corporate enterprise value | $2,400 |
| DKL stake value after discount | $1,605 |
| Less standalone net debt | -$247 |
| Equity value | $3,757 |
| Fair value per share | $59.93 |
Built with Modeledge MCP
Connect your MCP client to research filings and earnings calls, then build a living financial model like this one.